Phase II Study of Aflibercept (VEGF-Trap) in Patients With Recurrent or Metastatic Urothelial Cancer, a California Cancer Consortium Trial
Titel:
Phase II Study of Aflibercept (VEGF-Trap) in Patients With Recurrent or Metastatic Urothelial Cancer, a California Cancer Consortium Trial
Auteur:
Twardowski, Przemyslaw Stadler, Walter M. Frankel, Paul Lara, Primo N. Ruel, Christopher Chatta, Gurkamal Heath, Elisabeth Quinn, David I. Gandara, David R.